News Search Results
Feb 23, 2026, 10:01 ET Global Fluoropolymer Market to Reach US$16.7 Billion by 2033, Growing at 5.1% CAGR - Persistence Market Research
Nanofiltration), Application (Water & Wastewater Treatment, Desalination, Industrial Processing, Food & Beverage Processing, Pharmaceutical & Biotechnology, and Misc.), and Regional Analysis for 2026 – 2033
More news about: Persistence Market Research Pvt. Ltd.
Feb 23, 2026, 10:00 ET THE LOCKWOOD GROUP WELCOMES TOTAL HEALTH
continuum.About The Lockwood GroupThe Lockwood Group is a global health care services organization that partners with pharmaceutical, biotechnology, and health care companies to translate complex science into compelling, measurable strategies. With integrated capabilities spanning medical communications,
More news about: The Lockwood Group
Feb 23, 2026, 09:36 ET NASDAQ: QURE INVESTOR ALERT: Berger Montague Advises uniQure N.V. (NASDAQ: QURE) Investors of an April 13, 2026 Deadline
CLICK HERE.uniQure, headquartered in Amsterdam, the Netherlands, is a biotechnology company focused on the development of gene therapies for severe diseases, including Huntington's disease (HD).The Complaint alleges
More news about: Berger Montague
Feb 23, 2026, 09:00 ET Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 23, 2026, 08:55 ET Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Jose Conejo-Garcia, M.D., Ph.D., Professor of Immunology in the
More news about: Anixa Biosciences, Inc.
Feb 23, 2026, 08:40 ET "Would You Clone Yourself for a Cure?" Clonell Unveils White Paper on Fundamental Cures for 34 Incurable Diseases Using 'Human Cloning' Technology
cloning has long been a subject of dystopian science fiction and a stringent ethical taboo. However, Clonell Therapeutics, Inc., a cutting-edge biotechnology company, is actively shaking the landscape of regenerative medicine by bringing this powerful, historically controversial technology into the clinical
More news about: Clonell Therapeutics, Inc.
Feb 23, 2026, 08:33 ET Consano Bio to Present at BIO Investment & Growth Summit 2026
Consano Bio, a clinical-stage biotechnology company advancing novel therapeutics designed to address serious pain conditions, today announced that CEO Andrew Hall will present at the
More news about: Consano Bio
Feb 23, 2026, 08:00 ET Braveheart Bio to Participate in TD Cowen 46th Annual Health Care Conference
SAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ -- Braveheart Bio, a clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions, today announced that it will participate in the TD
More news about: Braveheart Bio
Feb 23, 2026, 07:00 ET PlantArcBio and Helix Sementes e Biotecnologia (Agroceres Group Company) Announce Licensing Collaboration to Advance High-Yield, Drought-Resilient Corn in South America
GIVAT CHEN, Israel and RIO CLARO, Brazil, Feb. 23, 2026 /PRNewswire/ -- PlantArcBio, an ag-biotechnology company pioneering precision biology for better crop performance, and Helix Sementes e Biotecnologia, a corn and sorghum seed company within
More news about: PlantArcBio and Agroceres Group
Feb 23, 2026, 07:00 ET Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02
Feb. 23, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Feb 23, 2026, 07:00 ET Promise Bio Launches Frontier Epiproteomic Innovation Grant, an R&D Access Initiative for Translational Epiproteomic Analysis
or additional laboratory procedures. Rooted in foundational research conducted at the Weizmann Institute of Science and featured in Nature Biotechnology in 2023, the proprietary technology allows for large-scale PTM profiling, helping researchers uncover disease mechanisms, tailor therapies, and
More news about: Promise Bio
Feb 23, 2026, 06:50 ET Functional Flour Market to Reach US$ 166.0 Billion by 2032 Expands Amid Rising Health Consciousness and Nutritional Innovation - Persistence Market Research
Nordmann in 2025A major development in the functional flour market was the new distribution agreement between French biotechnology firm Nutriearth and chemical distributor Nordmann to expand availability of N-utra, Nutriearth's mealworm-derived natural vitamin D3 functional
More news about: Persistence Market Research Pvt. Ltd.
Feb 23, 2026, 01:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Arrotex Pharmaceuticals.About Formosa Pharmaceuticals, Inc.Formosa Pharmaceuticals, Inc. (6838.TW) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation
More news about: Formosa Pharmaceuticals Inc.,
Feb 20, 2026, 13:06 ET Mecademic Secures Strategic Funding to Drive Global Expansion
next growth phase."Demand for Mecademic's micro-automation solutions is rising in sectors like electronics, optics, medical devices, and biotechnology. Its ultra-compact robotic arms allow manufacturers and labs to integrate high-speed, precise automation into confined spaces where traditional
More news about: Mecademic Industrial Robotics
Feb 20, 2026, 10:30 ET Sōlaria Biō Announces Study Demonstrating that the Microbe Blend in Bōndia™ Provides Maximum Bone Health Benefits
DensityBOSTON, Feb. 20, 2026 /PRNewswire/ -- Sōlaria Biō, a biotechnology company pioneering natural solutions for healthy aging, recently published the findings of a new open-label, randomized clinical study in
More news about: Sōlaria Biō
Feb 20, 2026, 09:15 ET AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence
received a $75 million task order from the U.S. Air Force to advance biotechnology and smart materials under the Functional Responsive Experimentation for Systems and Humans (FRESH) program at Wright Patterson Air Force Base in
More news about: USA News Group
Feb 20, 2026, 08:19 ET Aramore Featured in Forbes for Pioneering NAD+ Innovation in Beauty
aramoreskincare.com and select retail partners nationwide.About AramoreFounded at the intersection of biotechnology and beauty, Aramore is a pioneering skincare brand focused on longevity through cellular health. Backed by scientific research from MIT and Harvard,
More news about: ARAMORE Skincare
Feb 20, 2026, 08:00 ET Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
Prescribing Information, including Boxed WarningAbout Partner TherapeuticsPartner Therapeutics, Inc. (PTx), an integrated biotechnology company, focuses on development and commercialization of therapeutics to improve health outcomes in cancer and serious diseases, as well as global
More news about: Partner Therapeutics, Inc.
Feb 19, 2026, 19:29 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
[Click here for information about joining the class action]Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with,
More news about: Pomerantz LLP
Feb 19, 2026, 16:05 ET Tyra Biosciences to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Feb 19, 2026, 12:20 ET Antivenom Market to Reach $691.0 Million, Globally, by 2033 at 6.7% CAGR: Allied Market Research
foster the growth of the market. Technological innovation also plays a major role in the growth of the antivenom market.Advancements in biotechnology, including recombinant antibody technologies, monoclonal antibody approaches, and synthetic venom neutralizers also foster the growth of antivenom
More news about: Allied Market Research
Feb 19, 2026, 12:15 ET Patients with Crohn's disease maintained steroid-free remission for three years with Lilly's Omvoh (mirikizumab-mrkz)
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 19, 2026, 11:58 ET Bio Decontamination Market to Reach $525.4 million by 2033 Globally, at 8.7% CAGR: Allied Market Research
isolators, pass-through chambers, and controlled production environments.Pharmaceutical and biotechnology companies dominated the industry in 2023By end user, the pharmaceutical and biotechnology companies segment accounted for the largest market share in 2023, owing to strict regulatory
More news about: Allied Market Research
Feb 19, 2026, 11:16 ET Cystatin C Assay Market to Reach $750.7 million, Globally, by 2033 at 7.4% CAGR: Allied Market Research
Immunofluorescence Assay, and Others), Sample Type (Blood, Urine), Application (Diagnostics, Research), End User (Hospitals, Pharmaceutical & Biotechnology Companies, and Others), and Region (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2024-2033".
More news about: Allied Market Research
Feb 19, 2026, 09:00 ET Merlin CP-GEP Becomes the First and Only Gene Expression Profile (GEP) Test Recommended by NCCN® Cutaneous Melanoma Guidelines to Assess Metastatic Risk
www.merlinmelanomatest.com.About SkylineDxSkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, and inflammatory and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx